During the past decade, Hospital Universitario Infanta Sofia conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 7 clinical trials were completed, i.e. on average, 15.6% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 4 clinical trials were completed. i.e. 18.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Infanta Sofia" #1 sponsor was "PETHEMA Foundation" with 4 trials, followed by "Celgene" with 3 trials sponsored, "Hospital Infanta Sofia" with 3 trials sponsored, "Ipsen" with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Infanta Sofia" #1 collaborator was "Bristol-Myers Squibb" with 3 trials as a collaborator, "Dynamic Science S.L." with 2 trials as a collaborator, "Hospital Universitario 12 de Octubre" with 2 trials as a collaborator, "Instituto de Salud Carlos III" with 2 trials as a collaborator and "Adknoma" with 1 trials as a collaborator. Other collaborators include 36 different institutions and companies that were collaborators in the rest 46 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Infanta Sofia" are "COVID-19" (3 trials), "Epithelial Ovarian Cancer" (3 trials), "Fallopian Tube Cancer" (3 trials), "Multiple Myeloma" (3 trials) and "Covid19" (2 trials). Many other conditions were trialed in "Hospital Universitario Infanta Sofia" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Infanta Sofia" are "Drug" (31 trials), "Other" (12 trials), "Device" (6 trials), "Biological" (5 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Dexamethasone" (3 trials), "Bortezomib" (2 trials), "Methotrexate" (2 trials) and "ADT (androgen deprivation therapy)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Infanta Sofia" are 48 trials for "All" genders, 5 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Universitario Infanta Sofia". 1 are not yet recruiting, 9 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Hospital Universitario Infanta Sofia, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Infanta Sofia, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 5 trials that are defined as “Not Applicable".